Australia’s active vaccine safety system
AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues.
In the days following vaccination, responses are solicited via an automated SMS or email sent using AusVaxSafety surveillance tools (SmartVax or Vaxtracker), which have been implemented in more than 300 sentinel sites across Australia, including general practices, hospitals, schools, community clinics and Aboriginal Medical Services.
AusVaxSafety active vaccine safety surveillance sites across Australia = 304
(SmartVax surveillance tool = 290 and Vaxtracker surveillance tool = 14)
Analysis of de-identified responses occurs frequently and is reviewed by vaccine experts as well as the Australian Government of Health, including the Therapeutic Goods Administration. Key vaccine safety results are also available on the AusVaxSafety website.
The following vaccines are currently being actively monitored:
In January 2019 AusVaxSafety completed active surveillance of pertussis booster vaccine safety in children aged 12 months to 6 years after nearly three years of monthly monitoring. No safety signal was identified in children receiving DTPa at 18 months or DTPa-IPV at 4 years, with data contributed by over 55,000 participating parents/carers.
In November 2018 AusVaxSafety concluded active surveillance of zoster vaccine in adults aged 70–79 years after two years of fortnightly to monthly monitoring. No safety signal was identified in over 18,000 participants.
AusVaxSafety has also completed detailed vaccine safety analyses of all National Immunisation Program (NIP) vaccines using SmartVax data. The Vaccine safety in Australia AusVaxSafety summary report 2016–17 shows how parents and carers responded to an SMS about their child's health a few days after their vaccination at each schedule point in the NIP. 115,970 vaccination encounters were included in the analysis and the results confirm that vaccines on the NIP are safe.
In 2019, AusVaxSafety will implement active vaccine safety surveillance of all vaccines on the NIP Schedule.
AusVaxSafety receives fundingfrom the Australian Government
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS
Stay updated with the latest from ausvax